Related Experiment Video
Updated: Apr 10, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.8K
Government action on diabetes prevention: time to try something new
Jenny C Kaldor1, Roger S Magnusson2, Stephen Colagiuri3
1Sydney Law School, Sydney, NSW, Australia. jenny.kaldor@sydney.edu.au.
The Medical Journal of Australia
|June 13, 2015
Summary
Type 2 diabetes is rapidly increasing in Australia due to unhealthy diets and obesity. Addressing this requires shared responsibility and government regulation, including food labelling and sugar-sweetened beverage taxes.
Area of Science:
- Public Health
- Nutrition Science
- Health Policy
Background:
- Type 2 diabetes mellitus (T2DM) is Australia's fastest-growing non-communicable disease.
- Overweight and obesity, driven by unhealthy diets, are primary contributors to T2DM.
- Current approaches focusing on education and information provision are insufficient.
Purpose of the Study:
- To propose a paradigm shift in addressing T2DM in Australia.
- To identify priority areas for government regulation to combat rising T2DM rates.
- To advocate for increased government and food industry accountability.
Main Methods:
- Policy analysis and proposal development.
- Review of existing public health strategies for non-communicable diseases.
- Identification of regulatory interventions for the food environment.
Main Results:
- Four priority areas for government regulation are proposed.
- These areas include mandatory front-of-pack food labelling.
- Other areas include regulating junk food advertising, food reformulation oversight, and sugar-sweetened beverage taxation.
Conclusions:
- A shift towards shared responsibility is crucial for halting T2DM.
- Government regulation in key areas can significantly strengthen Australia's response to T2DM.
- Policy interventions targeting the food environment are essential for public health improvement.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
5.8K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.8K
01:15Diabetes: Management and Pharmacotherapy
1.5K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
980
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
980
01:22Diabetes Mellitus: Overview and Type I Subtype
6.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
6.2K
01:23Dipeptidyl Peptidase 4 Inhibitors
1.1K
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
1.1K
01:15Diabetes: Symptoms, Diagnosis, and Complications
2.9K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.9K